Dr Reddy’s had approached the Subject Expert committee (SEC) that advises the Drug Controller General of India (DCGI) on applications seeking permissions for new drugs, clinical trials, vaccines for Covid-19.
Copyright © 2024 | WordPress Theme by MH Themes